Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Drugs in Context|February 9, 2024
Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR<sup>+</sup>/HER2<sup>-</sup> metastatic breast cancer: a prospective, monocentric studyRaffaella Palumbo, Erica Quaquarini, Giuseppe Saltalamacchia, et al.
Clinical Breast Cancer|December 14, 2011
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trialsMaria Rosa Strada, Raffaella Palumbo, Antonio Bernardo, et al.
Journal of Clinical Medicine|February 25, 2023
Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease StageDavide Piloni, Francesco R Bertuccio, Cristiano Primiceri, et al.
Therapeutic Advances in Medical Oncology|September 30, 2020
Role of androgen receptor expression in early stage ER+/PgR-/HER2- breast cancerBarbara Tagliaferri, Erica Quaquarini, Raffaella Palumbo, et al.
Drugs in Context|May 19, 2025
Patterns of treatment and outcomes of patients with metastatic HER2-low breast cancer treated with CDK4/6 inhibitors and hormone therapyFederico Sottotetti, Barbara Tagliaferri, Gianpiero Rizzo, et al.
Cancers|September 27, 2025
Exposure to Occupational Carcinogens and Non-Oncogene Addicted Phenotype in Lung Cancer: Results from a Real-Life Observational StudyEnrico Oddone, Luca D'Amato, Roberta Pernetti, et al.
Clinical Nutrition ESPEN|July 25, 2024
Vitamin B12 status in hospitalised cancer patients: Prevalence and clinical implications of depletion and hypervitaminosisFederico Sottotetti, Alberto Malovini, Stefano Maccarone, et al.
Journal of Personalized Medicine|May 28, 2022
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre StudyErica Quaquarini, Federico Sottotetti, Francesco Agustoni, et al.
Cancers|October 15, 2020
Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy)Erica Quaquarini, Giuseppe Saltalamacchia, Daniele Presti, et al.
Drugs in Context|December 22, 2025
Adjuvant abemaciclib in early-stage breast cancer: hypothesis-generating safety observations from a real-world cohort studyFederico Sottotetti, Simone Figini, Giulia Gambini, et al.
Pageof 5